2018 / 04

Next Paper
DOI: 10.24075/brsmu.2018.054

REVIEW

The proper structure of a biosafety system as a way of reducing the vulnerability of a society, economy or state in the face of a biogenic threat

Gushchin VA1,2, Manuilov VA3, Makarov VV4, Tkachuk AP3
About authors

1 Laboratory of Population Variability Mechanisms in Pathogenic Microorganisms, Gamaleya Research Institute of Epidemiology and Microbiology, Moscow

2 Department of Virology, Faculty of Biology, Lomonosov Moscow State University, Moscow

3 Laboratory of Translational Medicine, Gamaleya Research Institute of Epidemiology and Microbiology, Moscow

4 Center for Strategic Planning of the Ministry of Health of the Russian Federation, Moscow

Correspondence should be addressed: Vladimir A. Gushchin
Gamalei 18, Moscow, 123098; moc.liamg@adainawow

About paper

Funding: this work was supported by the Ministry of Health of the Russian Federation as part of the project The National System for Chemical and Biological Security of the Russian Federation (2015-2020) and by the Ministry of Education and Science as part of the project RFMEFI60117X0018.

Received: 2018-09-30 Accepted: 2018-10-14 Published online: 2018-10-20
|
  1. O biologicheskoj bezopasnosti. Proekt Federal'nogo zakona Rossijskoj Federacii. (red. ot avgusta 2016 g.). 30 s. Dostupno po ssylke: http://regulation.gov.ru/projects#npa=55658
  2. Onishhenko GG, Popova AJu, Toporkov VP, Smolenskii VJu, Shherbakova SA, Kutyrev VV. Sovremennye ugrozy i vyzovy v oblasti biologicheskoj bezopasnosti i strategija protivodejstvija. Problemy osobo opasnyh infekcij. 2015; (3): 5–9.
  3. O sostojanii sanitarno-jepidemiologicheskogo blagopoluchija naselenija v Rossijskoj Federacii v 2017 godu: Gosudarstvennyj doklad. M.: Federal'naja sluzhba po nadzoru v sfere zashhity prav potrebitelej i blagopoluchija cheloveka; 2018. 268 s.
  4. Pokrovskij VI, Briko NI. Jepidemiologija. Uchebnik. M.: GJeOTAR-Media; 2016. 368 s.
  5. Lobzin JuV, Belozerov ES, Beljaeva TV, Volzhanin VM. Virusnye bolezni cheloveka. SPb.: SpecLit; 2015. 400 s.
  6. BioWatch and public health surveillance: Evaluating systems for the early detection of biological threats. Abbreviated version. Washington, DC: The National Academies Press. IOM and NRC. 2011. 252 р.
  7. Onishhenko GG, Merkulov IV, Petrov EJu, Zhelobov VE, Shevchuk NA, Seledcova OV. O hode immunizacii naselenija v ramkah nacional'nogo kalendarja profilakticheskih privivok. Protokol selektornogo soveshhanija u rukovoditelja Federal'noj sluzhby po nadzoru v sfere zashhity prav potrebitelej i blagopoluchija cheloveka (Protokol #13 ot 20.07.2010). Dostupno po ssylke: http://41.rospotrebnadzor.ru/content/protokol-protokol-selektornogo-soveshchaniya-u-rukovoditelya-federalnoy-sluzhby-po-nadzoru-5
  8. Osnovy gosudarstvennoj politiki v oblasti obespechenija himicheskoj i biologicheskoj bezopasnosti Rossijskoj Federacii na period do 2025 goda i dal'nejshuju perspektivu (utv. Prezidentom RF 1 nojabrja 2013 g. N Pr-2573). Dostupno po ssylke: http://www.garant.ru/products/ipo/prime/doc/70423098/
  9. Ukaz Prezidenta RF ot 31.12.2015 N 683 «O Strategii nacional'noj bezopasnosti Rossijskoj Federacii». Dostupno po ssylke: http://www.consultant.ru/document/cons_doc_LAW_191669/
  10. V Rossii sozdadut Centr po bor'be s biologicheskimi ugrozami. [Jelektronnyj resurs] Paper 16 matra 2015. Dostupno po ssylke: https://iz.ru/news/584008 (last accessed 12 September 2018).
  11. Postanovlenie Pravitel'stva RF ot 30 ijunja 2004 g. N 322 «Ob utverzhdenii Polozhenija o Federal'noj sluzhbe po nadzoru v sfere zashhity prav potrebitelej i blagopoluchija cheloveka» (v red. ot 24 janvarja 2017 g.). Dostupno po ssylke: http://base.garant.ru/12136005/
  12. Prikaz Federal'noj sluzhby gosudarstvennoj statistiki ot 28 janvarja 2014 g. N 52 «Ob utverzhdenii statisticheskogo instrumentarija dlja organizacii Federal'noj sluzhboj po nadzoru v sfere zashhity prav potrebitelej i blagopoluchija cheloveka federal'nogo statisticheskogo nabljudenija za zabolevaemost'ju naselenija infekcionnymi i parazitarnymi boleznjami i profilakticheskimi privivkami». Dostupno po ssylke: http://www.garant.ru/products/ipo/prime/doc/70479106/
  13. Statisticheskij uchet i otchetnost' uchrezhdenij zdravoohranenija. M.: Ministerstvo zdravoohranenija i social'nogo razvitija Rossijskoj Federacii. 2006. 81 s.
  14. Federal'nyj zakon ot 30.03.1999 N 52-FZ «O sanitarno-jepidemiologicheskom blagopoluchii naselenija» (v red. ot 03.07.2016). Dostupno po ssylke: http://www.consultant.ru/document/cons_doc_LAW_22481/
  15. Postanovlenie Pravitel'stva RF ot 2 fevralja 2006 g. N 60 «Ob utverzhdenii Polozhenija o provedenii social'no-gigienicheskogo monitoringa» (v red. ot 4 sentjabrja 2012 g.). Dostupno po ssylke: http://base.garant.ru/12144791/
  16. SanPiN 2.3.2.1078-01. Gigienicheskie trebovanija bezopasnosti i pishhevoj cennosti pishhevyh produktov. Utverzhdeny glavnym gosudarstvennym sanitarnym vrachom Rossijskoj Federacii 06 nojabrja 2001 g. Dostupno po ssylke: http://base.garant.ru/4178234/
  17. SanPiN 2.1.4.1074-01: Pit'evaja voda. Gigienicheskie trebovanija k kachestvu vody centralizovannyh sistem pit'evogo vodosnabzhenija. Kontrol' kachestva. Gigienicheskie trebovanija k obespecheniju bezopasnosti sistem gorjachego vodosnabzhenija. Utverzhdeny glavnym gosudarstvennym sanitarnym vrachom Rossijskoj Federacii 29 sentjabrja 2001 g. Dostupno po ssylke: http://docs.cntd.ru/document/901798042
  18. Perechen' standartov, soderzhashhih pravila i metody ispytanij i izmerenij, v tom chisle pravila otbora obrazcov, neobhodimye dlja primenenija i ispolnenija trebovanij tehnicheskogo reglamenta Tamozhennogo sojuza «Trebovanija bezopasnosti pishhevyh dobavok, aromatizatorov i tehnologicheskih vspomogatel'nyh sredstv» i osushhestvlenija ocenki (podtverzhdenija) sootvetstvija. Prilozhenie k Edinym sanitarno-jepidemiologicheskim i gigienicheskim trebovanijam k tovaram, podlezhashhim sanitarno-jepidemiologicheskomu nadzoru (kontrolju). Utverzhdeny Resheniem Komissii Tamozhennogo sojuza ot 28 maja 2010 goda # 299. (v red. ot 09 dekabrja 2011 g.)
  19. Dzenitis JM, Makarewicz AJ. The Autonomous Pathogen Detection System. The Microflow Cytometer. 2010: 263–84.
  20. Hindson BJ, Makarewicz AJ, Setlur US, Henderer BD, McBride MT, Dzenitis JM. APDS: the autonomous pathogen detection system. Biosens Bioelectron. 2005; 20 (10): 1925–31.
  21. Onishhenko GG, Kuzkin BP, Demina JuV. i dr. Obespechenie gotovnosti i organizacija raboty SPJeB FKUZ «Stavropol'skij protivochumnyj institut» Rospotrebnadzora v period provedenija XXII Olimpijskih i XI Paralimpijskih zimnih igr v Sochi. Problemy osobo opasnyh infekcij. 2015; (1): 58–62.
  22. GAO-14-267T BIOSURVEILLANCE: Observations on the Cancellation of BioWatch Gen-3 and Future Considerations for the Program. GAO. Statement of Chris Currie, Acting Director, Homeland Security and Justice. Washington, D.C.: 2014.
  23. Fournier PE, Raoult D. Prospects for the future using genomics and proteomics in clinical microbiology. Annu Rev Microbiol. 2011; (65): 169–188.
  24. Diene SM, Bertelli C, Pillonel T, Schrenzel J, Greub G. Bacterial genomics and metagenomics: clinical applications and medical relevance. Rev Med Suisse. 2014; 10 (450): 2155–61.
  25. Zhou K, Ferdous M, de Boer RF, Kooistra-Smid AM, Grundmann H, Friedrich AW, et al. The mosaic genome structure and phylogeny ofShiga toxin-producing Escherichia coli O104:H4 is driven by short-termadaptation. Clin Microbiol Infect. 2015; 21 (468): e467–18.
  26. Zhou K, Lokate M, Deurenberg RH, Tepper M, Arends JP, Raangs EG, et al. Use ofwhole-genome sequencing to trace, control and characterize the regionalexpansion of extended-spectrum beta-lactamase producing ST15 Klebsiellapneumoniae. Sci Rep. 2016; (6): 20840.
  27. Weterings V, Zhou K, Rossen JW, van Stenis D, Thewessen E, Kluytmans J, et al. An outbreak of colistin-resistant Klebsiella pneumoniaecarbapenemase-producing Klebsiella pneumoniae in the Netherlands (July–December 2013), with inter-institutional spread. Eur J Clin Microbiol Infect Dis. 2015; (34): 1647–55.
  28. Ferdous M, Zhou K, de Boer RF, Friedrich AW, Kooistra- Smid AM, Rossen JW, Comprehensive characterization of Escherichia coli O104:H4isolated from patients in the Netherlands. Front Microbiol. 2015; (6): 1348.
  29. Bathoorn E, Rossen JW, Lokate M, Friedrich AW, Hammerum AM. Isolation of an NDM-5-producing ST16 Klebsiella pneumoniae from a Dutchpatient without travel history abroad, August 2015. Euro Surveil. 2015; (20): 30040.
  30. Falgenhauer L, Waezsada SE, Yao Y, Imirzalioglu C, Kasbohrer A, Chakraborty T. Colistin resistance gene mcr-1 in extended-spectrumbeta-lactamase-producing and carbapenemase-producing Gram-negativebacteria in Germany. Lancet Infect Dis. 2016; (16): 282–283.
  31. Aanensen DM, Feil EJ, Holden MT, Dordel J, Yeats CA, Fedosejev A, et al. Whole-genome sequencing for routine pathogen surveillancein public health: a population snapshot of invasive Staphylococcus aureus in Europe. Mbio. 2016; 7 (3): e00444–16.
  32. Fournier PE, Dubourg G, Raoult D. Clinical detection and characterizationof bacterial pathogens in the genomics era. Genome Med. 2014; (6): 114.
  33. Hasman H, Saputra D, Sicheritz-Ponten T, Lund O, Svendsen CA, Frimodt-Moller N, et al. Rapid whole-genome sequencing fordetection and characterization of microorganisms directly from clinicalsamples. J Clin Microbiol. 2014; (52): 139–46.
  34. Franz E, Delaquis P, Morabito S, Beutin L, Gobius K, Rasko DA, et al. Exploiting the explosion ofinformation associated with whole genome sequencing to tackle Shigatoxin-producing Escherichia coli (STEC) in global food production systems. Int J Food Microbiol. 2014; (187): 57–72.
  35. Laabei M, Recker M, Rudkin JK, Aldeljawi M, Gulay Z, Sloan TJ, et al. Predicting the virulence of MRSA from its genome sequence. Genome Res. 2014; (24): 839–49.
  36. Ferdous M, Friedrich AW, Grundmann H, de Boer RF, Croughs PD, Islam MA, et al. Molecular characterization and phylogeny of Shiga toxin-producingEscherichia coli isolates obtained from two Dutch regions using whole genomesequencing. Clin Microbiol Infect 2016; (22): 642.e1–642.e9.
  37. Nijhuis RH, Oueslati S, Zhou K, Bosboom RW, Rossen JW, Naas T, et al. OXY-2-15, a novel variant showing increased ceftazidime hydrolytic activity. J Antimicrob Chemother. 2015; (70): 1429–33.
  38. Hasman H, Saputra D, Sicheritz-Ponten T, Lund O, Svendsen CA, Frimodt-Moller N, et al. Rapid whole-genome sequencing fordetection and characterization of microorganisms directly from clinicalsamples. J Clin Microbiol 2014; (52): 139–46.
  39. Patel JB. 16S rRNA gene sequencing for bacterial pathogen identification inthe clinical laboratory. Mol Diagn. 2001; (6): 313–21.
  40. Schuurman T, de Boer RF, Kooistra-Smid AM, van Zwet AA. Prospectivestudy of use of PCR amplification and sequencing of 16S ribosomal DNA fromcerebrospinal fluid for diagnosis of bacterial meningitis in a clinical setting. J Clin Microbiol. 2004; (42): 734–40.
  41. Srinivasan L, Pisapia JM, Shah SS, Halpern CH, Harris MC. Canbroad-range 16S ribosomal ribonucleic acid gene polymerase chain reactionsimprove the diagnosis of bacterial meningitis? A systematic review andmeta-analysis. Ann Emerg Med. 2012; (60): 609–20.
  42. Kalia VC, Kumar R, Kumar P, Koul S. A genome-wide profiling strategy asan aid for searching unique identification biomarkers for Streptococcus. Indian J Microbiol. 2016; (56): 46–58.
  43. Sabat AJ, van Zanten E, Akkerboom V, Wisselink G, van Slochteren K, de Boer RF. Targetedamplification for bacterial identification at the species-level usingnext-generation sequencing—increased discrimination of closely relatedspecies. ECCMID. 2016; E-poster EP0219.
  44. Daubin V, Gouy M, Perriere G. Bacterial molecular phylogeny usingsupertree approach. Genome Inform. 2001; (12): 155–64.
  45. Thompson CC, Chimetto L, Edwards RA, Swings J, Stackebrandt E, Thompson FL. Microbial genomic taxonomy. BMC Genom. 2013; (14): 913.
  46. Tenover FC, Arbeit RD, Goering RV. How to select and interpretmolecular strain typing methods for epidemiological studies of bacterialinfections: a review for healthcare epidemiologists. Molecular Typing WorkingGroup of the Society for Healthcare Epidemiology of America. Infect Control Hosp Epidemiol. 1997; (18): 426–39.
  47. Sabat AJ, Budimir A, Nashev D, Sa-Leao R, van Dijl J, Laurent F, et al. Overview of molecular typing methods for outbreakdetection and epidemiological surveillance. Euro Surveil. 2013; (18): 20380.
  48. Harrison EM, Paterson GK, Holden MT, Larsen J, Stegger M, Larsen AR, et al. Whole genomesequencing identifies zoonotic transmission of MRSA isolates with the novelmecA homologue mecC. EMBO Mol Med. 2013; (5): 509–15.
  49. Makarov VV, Hromov AV, Gushhin VA, Tkachuk AP. Vozniknovenie novyh infekcij v 21 veke i sposoby ih identifikacii s ispol'zovaniem vysokoproizvoditel'nogo sekvenirovanija (NGS). Vestnik RGMU. 2017; (1): 5–25.
  50. Jakovlev SV, Suvorova MP, Beloborodov VB, Basin EE, Eliseeva EV, Kovelenov SV. i dr. Rasprostranennost' i klinicheskoe znachenie nozokomial'nyh infekcij v lechebnyh uchrezhdenijah Rossii: issledovanie JeRGINI. Antibiotiki i himioterapija 2016; 61 (5–6): 32–42.
  51. Kozlov RS. Pnevmokokki: uroki proshlogo — vzgljad v budushhee. Smolensk: MAKMAH; 2010.
  52. Paterson DL, Rossi F, Baquero F, et al. In vitro susceptibilities of aerobic and facultative Gram-negative bacilli isolated from patient with intra-abdominal infections worldwide: the 2003 Study for Monitoring Antimicrobial Resistance Trend (SMART). J Antimicrob Chemother. 2005; (55): 965–73.
  53. Nauchnyj otchet o rezul'tatah issledovanija antibiotikorezistentnosti bakterial'nyh vozbuditelej nozokomial'nyh infekcij v otdelenijah s intensivnym ispol'zovaniem antibiotikov v stacionarah Rossii (ReVANSh). Smolensk: Nauchno-issledovatel'skij institut antimikrobnoj himioterapii; 2009.
  54. Bonomo RA, Burd EM, Conly J, Limbago BM, Poirel L, Segre JA, Westblade LF. Carbapenemase-Producing Organisms: A Global Scourge. Clin Infect Dis. 2017 Oct 16.
  55. Kohler PP, Volling C, Green K, Uleryk EM, Shah PS, McGeer A. Carbapenem Resistance, Initial Antibiotic Therapy, and Mortality in Klebsiella pneumoniae Bacteremia: A Systematic Review and Meta-Analysis. Infect Control Hosp Epidemiol. 2017 Nov; 38 (11): 1319–28.
  56. Zavascki AP, Barth AL, Gaspareto PB, et al. Risk factors for nosocomial infections due to Pseudomonas aeruginosa producing metallo-beta-lactamase in two tertiary-care teaching hospitals. J Antimicrob Chemother. 2006; (58): 882–5.
  57. Messadi AA, Lamia T, Kamel B, et al. Association between antibiotic use and changes in susceptibility patterns of P. aeruginosa in an intensive care unit: a 5-year study, 2000– 2004. Burns. 2008; (34):1098–102.
  58. Jakovlev SV, Procenko DN, Shahova TV. i dr. Antibiotikorezistentnost' v stacionare: kontroliruem li my situaciju? Antibiotiki i himioterapija. 2010; 55 (1–2): 50–58.
  59. Tacconelli E, De Angelis G, Cataldo MA, et al. Does antibiotic exposure increase the risk of methicillinresistant Staphylococcus aureus (MRSA) isolation? A systematic review and meta-analysis. J Antimicrob Chemother. 2008; (61): 26– 38.
  60. Sarma JB, Ahmed GU. Characterisation of methicillin resistant S. aureus strains and risk factors for acquisition in a teaching hospital in northeast India. Indian J Med Microbiol. 2010; (28): 127–9.
  61. Fair RJ, Tor Y. Antibiotics and bacterial resistance in the 21st century. Perspect Med Chem. 2014; (6): 25–64.
  62. Curcio D. Multidrug-resistant Gram-negative bacterial infections: are you ready for the challenge? Curr Clin Pharmacol. 2014; (9): 27–38.
  63. De Angelis GD, D’Inzeo T, Fiori B, et al. Burden of antibiotic resistant Gram-negative bacterial infections: evidence and limits. J Med Microbiol Diagn. 2014; (3) :132–37.
  64. Global'nyj plan dejstvij po bor'be s ustojchivost'ju k protivomikrobnym preparatam. VOZ. 2016 g. 7 s. Dostupno po ssylke: http://apps.who.int/gb/ebwha/pdf_files/WHA69/A69_24-ru.pdf
  65. Jakovlev SV, Procenko DN, Shahova TV. i dr. Antibiotikorezistentnost' v stacionare: kontroliruem li my situaciju? Antibiotiki i himioterapija. 2010; 55 (1–2): 50–8.
  66. Jakovlev SV, Sidorenko SV, Rafal'skij VV, Spichak TV, redaktory. Strategija i taktika racional'nogo primenenija antimikrobnyh sredstv v ambulatornoj praktike. Rossijskie prakticheskie rekomendacii. M.: Izdatel'stvo «Pre100print»; 2014. 121 s.
  67. Blair JM, Webber MA, Baylay AJ, et al. Molecular mechanisms of antibiotic resistance. Nat Rev Microbiol. 2015; (13): 42–51.
  68. The Protocol for the Prohibition of the Use in War of Asphyxiating, Poisonous or Other Gases, and of Bacteriological Methods of Warfare. United Nations (1925). Available from: http://www. un.org/disarmament/WMD/Bio/1925GenevaProtocol.shtml (last accessed 12 December 2015).
  69. World Health Organization. Public health response to biological and chemical weapons — WHO guidance, 2nd edn. Geneva: WHO, 2004.
  70. Nuclear Threat Initiative. Available from: http://www.nti.org/country-profiles (last accessed 12 December 2015).
  71. Atlas RM. The medical threat of biological weapons. Crit Rev Microbiol. 1998; (24): 157–68.
  72. Leitenberg M, Zilinskas RA, editors. The Soviet biological weapons program: a history. Cambridge, MA: Harvard University Press; 2012.
  73. Centers for Disease Control and Prevention. Webpage Emergency Preparedness and Response. Specific hazards: Bioterrorism. Available from: http://www.bt.cdc.gov/ bioterrorism (last accessed 12 December 2015).
  74. Carus WS. Bioterrorism and biocrimes: the illicit use of biological agents since 1900. February 2001 revision. Washington, DC: Center for Counter proliferation Research, National Defense University. 2001. Available from: http://www.fas.org/irp/ threat/cbw/carus.pdf (last accessed 12 December 2015).
  75. Ackermann GA, Moran KS. Bioterrorism and threat assessment. Weapons of Mass Destruction Commission. 2004. Available from: www.blixassociates.com/wp-content/uploads/2011/03/No22.pdf (last accessed 12 December 2015).
  76. Dando M. Bioterrorism: what is the real threat? Science and Technology Report No. 3. UK Global Health Policy Programme. London: The Nuffield Trust, 2005.
  77. Kolavic SA, Kimura A, Simons SL, et al. An outbreak of Shigella dysenteriae Type 2 among laboratory workers due to intentional food contamination. JAMA. 1997; (278): 396–8.
  78. Wheelis M, Casagrande R, Madden LV. Biological attack on agriculture: low-tech, high-impact bioterrorism. Bioscience. 2002; (52): 569–76.
  79. Bourn J. The 2001 Outbreak of Foot and Mouth Disease. Report by the Comptroller and Auditor General, HC 939 Session 2001–2002. London, UK, National Audit Office. 2002. Available from: www.nao.gov.uk (last accessed 12 December 2015).
  80. Meuwissen MPM, Van Boven M, Hagenaars TJ, et al. Predicting future costs of high-pathogenicity avian influenza epidemics: large versus small uncertainties. NJAS. 2006; (52): 195–205.
  81. Schmitt K, Zacchia NA. Total decontamination cost of the anthrax letter attacks. Biosecur Bioterror. 2012; (10): 1–10.
  82. Gibson DG, Glass JI, Lartigue C, Noskov VN, Chuang RY, Algire MA, et al. Creation of a bacterial cell controlled by a chemically synthesized genome. Science. 2010 Jul 2; 329 (5987): 52–6. DOI: 10.1126/science.1190719.
  83. Gibson DG, Venter JC. Synthetic biology: Construction of a yeast chromosome. Nature. 2014 May 8; 509 (7499): 168–9. DOI: 10.1038/509168a.
  84. Hutchison CA, Chuang RY, Noskov VN, Assad-Garcia N, Deerinck TJ, Ellisman MH, et al. Design and synthesis of a minimal bacterial genome. Science. 2016 Mar 25; 351 (6280): aad6253. DOI: 10.1126/science.aad6253 .
  85. Boles KS, Kannan K, Gill J, Felderman M, Gouvis H, Hubby B, et al. Digital-to-biological converter for on-demand production of biologics. Nature Biotechnology. 2017; (35): 672–5